IL6 and atherosclerosis: Thus, activation of the NLRP3 inflammasome triggers an inflammatory cascade that culminates in increased plasma IL-6 and hsCRP levels, both associated with higher ASCVD event rates.13,14 Currently, hsCRP is the primary plasma biomarker used clinically to identify systemic inflammation (Figure 1).